Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals

BACKGROUND: Treatment response to antiviral drugs is a challenging issue in patients with chronic hepatitis C virus (HCV) infection. Although microRNA-122 represents the majority of the microRNA content in hepatic tissues, few studies have evaluated its role in the treatment response, so we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Elabd, Naglaa S, Tayel, Safaa I, Elhamouly, Moamena S, Hassanein, Shaimaa A, Kamaleldeen, Samar M, Ahmed, Fatma E, Rizk, Mahmoud, Gadallah, Abdelnaser A, Ajlan, Soma E, Sief, Ahmed S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979684/
https://www.ncbi.nlm.nih.gov/pubmed/33758557
http://dx.doi.org/10.2147/HMER.S292251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979684/
https://www.ncbi.nlm.nih.gov/pubmed/33758557
http://dx.doi.org/10.2147/HMER.S292251

Ejemplares similares